Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H8N6O |
| Molecular Weight | 192.178 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(N)=C2N=C(CO)C=NC2=N1
InChI
InChIKey=CYNARAWTVHQHDI-UHFFFAOYSA-N
InChI=1S/C7H8N6O/c8-5-4-6(13-7(9)12-5)10-1-3(2-14)11-4/h1,14H,2H2,(H4,8,9,10,12,13)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. | 1999 Aug 26 |
|
| Design, synthesis, computational prediction, and biological evaluation of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii. | 2001 Jul 19 |
|
| Determination of the chiral and achiral related substances of methotrexate by cyclodextrin-modified micellar electrokinetic chromatography. | 2004 Aug |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 Jun |
|
| Plasmodium berghei: lack of antimalarial activity of an analogue of folate precursor, 2,4-diamino-6-hydroxymethylpteridine in a mouse model. | 2008 Nov |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID10915479
Created by
admin on Sat Dec 16 08:04:57 GMT 2023 , Edited by admin on Sat Dec 16 08:04:57 GMT 2023
|
PRIMARY | |||
|
945-24-4
Created by
admin on Sat Dec 16 08:04:57 GMT 2023 , Edited by admin on Sat Dec 16 08:04:57 GMT 2023
|
PRIMARY | |||
|
1RU16O4RO0
Created by
admin on Sat Dec 16 08:04:57 GMT 2023 , Edited by admin on Sat Dec 16 08:04:57 GMT 2023
|
PRIMARY | |||
|
70347
Created by
admin on Sat Dec 16 08:04:57 GMT 2023 , Edited by admin on Sat Dec 16 08:04:57 GMT 2023
|
PRIMARY | |||
|
213-412-2
Created by
admin on Sat Dec 16 08:04:57 GMT 2023 , Edited by admin on Sat Dec 16 08:04:57 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
